| High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells LA Mathews Griner, R Guha, P Shinn, RM Young, JM Keller, D Liu, ... Proceedings of the National Academy of Sciences 111 (6), 2349-2354, 2014 | 409 | 2014 |
| Global synthetic-lethality analysis and yeast functional profiling SL Ooi, X Pan, BD Peyser, P Ye, PB Meluh, DS Yuan, RA Irizarry, ... TRENDS in Genetics 22 (1), 56-63, 2006 | 215 | 2006 |
| Gene function prediction from congruent synthetic lethal interactions in yeast P Ye, BD Peyser, X Pan, JD Boeke, FA Spencer, JS Bader Molecular systems biology 1 (1), 2005.0026, 2005 | 191 | 2005 |
| S-phase checkpoint genes safeguard high-fidelity sister chromatid cohesion CD Warren, DM Eckley, MS Lee, JS Hanna, A Hughes, B Peyser, C Jie, ... Molecular biology of the cell 15 (4), 1724-1735, 2004 | 152 | 2004 |
| Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen KB Spurgers, T Alefantis, BD Peyser, GT Ruthel, AA Bergeron, ... Molecular & Cellular Proteomics 9 (12), 2690-2703, 2010 | 81 | 2010 |
| Serological Studies Using Polyclonal Antisera Prepared Against the Viral Coat Protein of Four Begomoviruses Expressed in Escherichia coli AM Abouzid, J Freitas-Astua, DE Purcifull, JE Polston, KA Beckham, ... Plant Disease 86 (10), 1109-1114, 2002 | 43 | 2002 |
| Improved microarray methods for profiling the Yeast Knockout strain collection DS Yuan, X Pan, SL Ooi, BD Peyser, FA Spencer, RA Irizarry, JD Boeke Nucleic acids research 33 (12), e103-e103, 2005 | 41 | 2005 |
| Commensurate distances and similar motifs in genetic congruence and protein interaction networks in yeast P Ye, BD Peyser, FA Spencer, JS Bader BMC bioinformatics 6, 1-13, 2005 | 33 | 2005 |
| Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as … JE Nuss, K Kehn-Hall, A Benedict, J Costantino, M Ward, BD Peyser, ... PLoS One 9 (5), e93483, 2014 | 32 | 2014 |
| Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients EE Perez, SL Rose, B Peyser, SL Lamers, B Burkhardt, BM Dunn, ... The Journal of infectious diseases 183 (4), 579-588, 2001 | 32 | 2001 |
| Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection RG Panchal, SB Bradfute, BD Peyser, KL Warfield, G Ruthel, D Lane, ... Cell host & microbe 6 (2), 162-173, 2009 | 26 | 2009 |
| Src family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons E Kiris, JC Burnett, JE Nuss, LM Wanner, BD Peyser, HT Du, GY Gomba, ... Neurotoxicity research 27, 384-398, 2015 | 16 | 2015 |
| A threonine turnstile defines a dynamic amphiphilic binding motif in the AAA ATPase p97 allosteric binding site JC Burnett, C Lim, BD Peyser, LP Samankumara, M Kovaliov, R Colombo, ... Organic & biomolecular chemistry 15 (19), 4096-4114, 2017 | 14 | 2017 |
| Analysis of genetic interactions on a genome-wide scale in budding yeast: diploid-based synthetic lethality analysis by microarray PB Meluh, X Pan, DS Yuan, C Tiffany, O Chen, S Sookhai-Mahadeo, ... Microbial gene essentiality: Protocols and bioinformatics, 221-247, 2008 | 12 | 2008 |
| Improved statistical analysis of budding yeast TAG microarrays revealed by defined spike-in pools BD Peyser, RA Irizarry, CW Tiffany, O Chen, DS Yuan, JD Boeke, ... Nucleic acids research 33 (16), e140-e140, 2005 | 10 | 2005 |
| Integrating High-Content Imaging and Chemical Genetics to Probe Host Cellular Pathways Critical for Yersinia Pestis Infection KP Kota, B Eaton, D Lane, M Ulrich, R Ulrich, BD Peyser, CG Robinson, ... PLoS One 8 (1), e55167, 2013 | 9 | 2013 |
| Screen for new antimicrobial natural products from the NCI program for natural product discovery prefractionated extract library L Martínez-Fructuoso, SJR Arends, VF Freire, JR Evans, S DeVries, ... ACS Infectious Diseases 9 (6), 1245-1256, 2023 | 8 | 2023 |
| Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy BD Peyser, A Hermone, JM Salamoun, JC Burnett, MG Hollingshead, ... Molecular cancer therapeutics 18 (10), 1765-1774, 2019 | 5 | 2019 |
| Statistical analysis of fitness data determined by TAG hybridization on microarrays BD Peyser, R Irizarry, FA Spencer Microbial Gene Essentiality: Protocols and Bioinformatics, 369-381, 2008 | 4 | 2008 |
| Decreased DNA damage and improved p53 specificity of RITA analogs Y Zhan, X Zhou, S Peuget, M Singh, BD Peyser, Z Fan, G Selivanova Molecular cancer therapeutics 21 (10), 1524-1534, 2022 | 2 | 2022 |
Jef D. BoekeNYU Langone Health在 nyulangone.org 的电子邮件经过验证
